private:vyserabiomedical-2
|
792316
|
Dec 3rd, 2020 12:00AM
|
Vysera Biomedical Ltd
|
319
|
3.00
|
Open
|
Medical Device
|
Dec 3rd, 2020 03:22PM
|
Dec 3rd, 2020 03:22PM
|
Vysera, which commenced operations in 2005, is a medical devices company located in Galway, Ireland whose principal activity is the development of products and therapies that can be delivered directly to target sites on the inner surface of the gastrointestinal tract ("GI") via conventional, minimally invasive techniques.
The company has a developed unique proprietary biomimetic material technology and is applying this technology to address the significant unmet need for gastrointestinal reflux control (GERD).
GERD is a condition in which the contents of the stomach regurgitates (refluxes) into the esophagus. This reflux inflames and damages the lining of the esophagus, leading to complications including asthma, bronchitis and Barretts Esophagus (a pre-cancerous condition).
The technology has additional applications in urology, obesity and drug delivery which are in the early stages of development.
Vysera's Medical Scientific Advisory Board includes world leading clinicians, located at the Mayo Clinic, Beth Israel Hospital (Harvard Medical School) and Sahlgrenska Hospital in Gothenburg, Sweden. The Medical Scientific Advisory Board provides input and direction to product design, application and associated clinical procedures; with the clinicians providing facilities for extensive testing and product evaluation in a pre-clinical and clinical environment.
|
Open
|
|
|
BMR House, Parkmore Business Park West
|
Galway
|
|
IE
|
Ireland
|
|
Vysera Biomedical
|
|
Pharmaceuticals & Biotechnology
|
private:vyserabiomedical-2
|
792316
|
Dec 2nd, 2020 12:00AM
|
Vysera Biomedical Ltd
|
319
|
3.00
|
Open
|
Medical Device
|
Dec 2nd, 2020 05:09PM
|
Dec 2nd, 2020 05:09PM
|
Vysera, which commenced operations in 2005, is a medical devices company located in Galway, Ireland whose principal activity is the development of products and therapies that can be delivered directly to target sites on the inner surface of the gastrointestinal tract ("GI") via conventional, minimally invasive techniques.
The company has a developed unique proprietary biomimetic material technology and is applying this technology to address the significant unmet need for gastrointestinal reflux control (GERD).
GERD is a condition in which the contents of the stomach regurgitates (refluxes) into the esophagus. This reflux inflames and damages the lining of the esophagus, leading to complications including asthma, bronchitis and Barretts Esophagus (a pre-cancerous condition).
The technology has additional applications in urology, obesity and drug delivery which are in the early stages of development.
Vysera's Medical Scientific Advisory Board includes world leading clinicians, located at the Mayo Clinic, Beth Israel Hospital (Harvard Medical School) and Sahlgrenska Hospital in Gothenburg, Sweden. The Medical Scientific Advisory Board provides input and direction to product design, application and associated clinical procedures; with the clinicians providing facilities for extensive testing and product evaluation in a pre-clinical and clinical environment.
|
Open
|
|
|
BMR House, Parkmore Business Park West
|
Galway
|
|
IE
|
Ireland
|
|
Vysera Biomedical
|
|
Pharmaceuticals & Biotechnology
|
private:vyserabiomedical-2
|
792316
|
Dec 1st, 2020 12:00AM
|
Vysera Biomedical Ltd
|
319
|
3.00
|
Open
|
Medical Device
|
Dec 1st, 2020 03:44PM
|
Dec 1st, 2020 03:44PM
|
Vysera, which commenced operations in 2005, is a medical devices company located in Galway, Ireland whose principal activity is the development of products and therapies that can be delivered directly to target sites on the inner surface of the gastrointestinal tract ("GI") via conventional, minimally invasive techniques.
The company has a developed unique proprietary biomimetic material technology and is applying this technology to address the significant unmet need for gastrointestinal reflux control (GERD).
GERD is a condition in which the contents of the stomach regurgitates (refluxes) into the esophagus. This reflux inflames and damages the lining of the esophagus, leading to complications including asthma, bronchitis and Barretts Esophagus (a pre-cancerous condition).
The technology has additional applications in urology, obesity and drug delivery which are in the early stages of development.
Vysera's Medical Scientific Advisory Board includes world leading clinicians, located at the Mayo Clinic, Beth Israel Hospital (Harvard Medical School) and Sahlgrenska Hospital in Gothenburg, Sweden. The Medical Scientific Advisory Board provides input and direction to product design, application and associated clinical procedures; with the clinicians providing facilities for extensive testing and product evaluation in a pre-clinical and clinical environment.
|
Open
|
|
|
BMR House, Parkmore Business Park West
|
Galway
|
|
IE
|
Ireland
|
|
Vysera Biomedical
|
|
Pharmaceuticals & Biotechnology
|
private:vyserabiomedical-2
|
792316
|
Nov 30th, 2020 12:00AM
|
Vysera Biomedical Ltd
|
319
|
3.00
|
Open
|
Medical Device
|
Nov 29th, 2020 09:41PM
|
Nov 30th, 2020 06:39PM
|
Vysera, which commenced operations in 2005, is a medical devices company located in Galway, Ireland whose principal activity is the development of products and therapies that can be delivered directly to target sites on the inner surface of the gastrointestinal tract ("GI") via conventional, minimally invasive techniques.
The company has a developed unique proprietary biomimetic material technology and is applying this technology to address the significant unmet need for gastrointestinal reflux control (GERD).
GERD is a condition in which the contents of the stomach regurgitates (refluxes) into the esophagus. This reflux inflames and damages the lining of the esophagus, leading to complications including asthma, bronchitis and Barretts Esophagus (a pre-cancerous condition).
The technology has additional applications in urology, obesity and drug delivery which are in the early stages of development.
Vysera's Medical Scientific Advisory Board includes world leading clinicians, located at the Mayo Clinic, Beth Israel Hospital (Harvard Medical School) and Sahlgrenska Hospital in Gothenburg, Sweden. The Medical Scientific Advisory Board provides input and direction to product design, application and associated clinical procedures; with the clinicians providing facilities for extensive testing and product evaluation in a pre-clinical and clinical environment.
|
Open
|
|
|
BMR House, Parkmore Business Park West
|
Galway
|
|
IE
|
Ireland
|
|
Vysera Biomedical
|
|
Pharmaceuticals & Biotechnology
|
private:vyserabiomedical-2
|
792316
|
Nov 28th, 2020 12:00AM
|
Vysera Biomedical Ltd
|
319
|
3.00
|
Open
|
Medical Device
|
Nov 28th, 2020 05:14PM
|
Nov 28th, 2020 05:14PM
|
Vysera, which commenced operations in 2005, is a medical devices company located in Galway, Ireland whose principal activity is the development of products and therapies that can be delivered directly to target sites on the inner surface of the gastrointestinal tract ("GI") via conventional, minimally invasive techniques.
The company has a developed unique proprietary biomimetic material technology and is applying this technology to address the significant unmet need for gastrointestinal reflux control (GERD).
GERD is a condition in which the contents of the stomach regurgitates (refluxes) into the esophagus. This reflux inflames and damages the lining of the esophagus, leading to complications including asthma, bronchitis and Barretts Esophagus (a pre-cancerous condition).
The technology has additional applications in urology, obesity and drug delivery which are in the early stages of development.
Vysera's Medical Scientific Advisory Board includes world leading clinicians, located at the Mayo Clinic, Beth Israel Hospital (Harvard Medical School) and Sahlgrenska Hospital in Gothenburg, Sweden. The Medical Scientific Advisory Board provides input and direction to product design, application and associated clinical procedures; with the clinicians providing facilities for extensive testing and product evaluation in a pre-clinical and clinical environment.
|
Open
|
|
|
BMR House, Parkmore Business Park West
|
Galway
|
|
IE
|
Ireland
|
|
Vysera Biomedical
|
|
Pharmaceuticals & Biotechnology
|
private:vyserabiomedical-2
|
792316
|
Nov 27th, 2020 12:00AM
|
Vysera Biomedical Ltd
|
319
|
3.00
|
Open
|
Medical Device
|
Nov 27th, 2020 01:40PM
|
Nov 27th, 2020 01:40PM
|
Vysera, which commenced operations in 2005, is a medical devices company located in Galway, Ireland whose principal activity is the development of products and therapies that can be delivered directly to target sites on the inner surface of the gastrointestinal tract ("GI") via conventional, minimally invasive techniques.
The company has a developed unique proprietary biomimetic material technology and is applying this technology to address the significant unmet need for gastrointestinal reflux control (GERD).
GERD is a condition in which the contents of the stomach regurgitates (refluxes) into the esophagus. This reflux inflames and damages the lining of the esophagus, leading to complications including asthma, bronchitis and Barretts Esophagus (a pre-cancerous condition).
The technology has additional applications in urology, obesity and drug delivery which are in the early stages of development.
Vysera's Medical Scientific Advisory Board includes world leading clinicians, located at the Mayo Clinic, Beth Israel Hospital (Harvard Medical School) and Sahlgrenska Hospital in Gothenburg, Sweden. The Medical Scientific Advisory Board provides input and direction to product design, application and associated clinical procedures; with the clinicians providing facilities for extensive testing and product evaluation in a pre-clinical and clinical environment.
|
Open
|
|
|
BMR House, Parkmore Business Park West
|
Galway
|
|
IE
|
Ireland
|
|
Vysera Biomedical
|
|
Pharmaceuticals & Biotechnology
|
private:vyserabiomedical-2
|
792316
|
Nov 26th, 2020 12:00AM
|
Vysera Biomedical Ltd
|
319
|
3.00
|
Open
|
Medical Device
|
Nov 25th, 2020 08:47PM
|
Nov 25th, 2020 08:47PM
|
Vysera, which commenced operations in 2005, is a medical devices company located in Galway, Ireland whose principal activity is the development of products and therapies that can be delivered directly to target sites on the inner surface of the gastrointestinal tract ("GI") via conventional, minimally invasive techniques.
The company has a developed unique proprietary biomimetic material technology and is applying this technology to address the significant unmet need for gastrointestinal reflux control (GERD).
GERD is a condition in which the contents of the stomach regurgitates (refluxes) into the esophagus. This reflux inflames and damages the lining of the esophagus, leading to complications including asthma, bronchitis and Barretts Esophagus (a pre-cancerous condition).
The technology has additional applications in urology, obesity and drug delivery which are in the early stages of development.
Vysera's Medical Scientific Advisory Board includes world leading clinicians, located at the Mayo Clinic, Beth Israel Hospital (Harvard Medical School) and Sahlgrenska Hospital in Gothenburg, Sweden. The Medical Scientific Advisory Board provides input and direction to product design, application and associated clinical procedures; with the clinicians providing facilities for extensive testing and product evaluation in a pre-clinical and clinical environment.
|
Open
|
|
|
BMR House, Parkmore Business Park West
|
Galway
|
|
IE
|
Ireland
|
|
Vysera Biomedical
|
|
Pharmaceuticals & Biotechnology
|
private:vyserabiomedical-2
|
792316
|
Nov 24th, 2020 12:00AM
|
Vysera Biomedical Ltd
|
319
|
3.00
|
Open
|
Medical Device
|
Nov 24th, 2020 04:20PM
|
Nov 24th, 2020 04:20PM
|
Vysera, which commenced operations in 2005, is a medical devices company located in Galway, Ireland whose principal activity is the development of products and therapies that can be delivered directly to target sites on the inner surface of the gastrointestinal tract ("GI") via conventional, minimally invasive techniques.
The company has a developed unique proprietary biomimetic material technology and is applying this technology to address the significant unmet need for gastrointestinal reflux control (GERD).
GERD is a condition in which the contents of the stomach regurgitates (refluxes) into the esophagus. This reflux inflames and damages the lining of the esophagus, leading to complications including asthma, bronchitis and Barretts Esophagus (a pre-cancerous condition).
The technology has additional applications in urology, obesity and drug delivery which are in the early stages of development.
Vysera's Medical Scientific Advisory Board includes world leading clinicians, located at the Mayo Clinic, Beth Israel Hospital (Harvard Medical School) and Sahlgrenska Hospital in Gothenburg, Sweden. The Medical Scientific Advisory Board provides input and direction to product design, application and associated clinical procedures; with the clinicians providing facilities for extensive testing and product evaluation in a pre-clinical and clinical environment.
|
Open
|
|
|
BMR House, Parkmore Business Park West
|
Galway
|
|
IE
|
Ireland
|
|
Vysera Biomedical
|
|
Pharmaceuticals & Biotechnology
|
private:vyserabiomedical-2
|
792316
|
Nov 23rd, 2020 12:00AM
|
Vysera Biomedical Ltd
|
319
|
3.00
|
Open
|
Medical Device
|
Nov 23rd, 2020 06:09PM
|
Nov 23rd, 2020 06:09PM
|
Vysera, which commenced operations in 2005, is a medical devices company located in Galway, Ireland whose principal activity is the development of products and therapies that can be delivered directly to target sites on the inner surface of the gastrointestinal tract ("GI") via conventional, minimally invasive techniques.
The company has a developed unique proprietary biomimetic material technology and is applying this technology to address the significant unmet need for gastrointestinal reflux control (GERD).
GERD is a condition in which the contents of the stomach regurgitates (refluxes) into the esophagus. This reflux inflames and damages the lining of the esophagus, leading to complications including asthma, bronchitis and Barretts Esophagus (a pre-cancerous condition).
The technology has additional applications in urology, obesity and drug delivery which are in the early stages of development.
Vysera's Medical Scientific Advisory Board includes world leading clinicians, located at the Mayo Clinic, Beth Israel Hospital (Harvard Medical School) and Sahlgrenska Hospital in Gothenburg, Sweden. The Medical Scientific Advisory Board provides input and direction to product design, application and associated clinical procedures; with the clinicians providing facilities for extensive testing and product evaluation in a pre-clinical and clinical environment.
|
Open
|
|
|
BMR House, Parkmore Business Park West
|
Galway
|
|
IE
|
Ireland
|
|
Vysera Biomedical
|
|
Pharmaceuticals & Biotechnology
|
private:vyserabiomedical-2
|
792316
|
Nov 22nd, 2020 12:00AM
|
Vysera Biomedical Ltd
|
319
|
3.00
|
Open
|
Medical Device
|
Nov 22nd, 2020 05:05PM
|
Nov 22nd, 2020 05:05PM
|
Vysera, which commenced operations in 2005, is a medical devices company located in Galway, Ireland whose principal activity is the development of products and therapies that can be delivered directly to target sites on the inner surface of the gastrointestinal tract ("GI") via conventional, minimally invasive techniques.
The company has a developed unique proprietary biomimetic material technology and is applying this technology to address the significant unmet need for gastrointestinal reflux control (GERD).
GERD is a condition in which the contents of the stomach regurgitates (refluxes) into the esophagus. This reflux inflames and damages the lining of the esophagus, leading to complications including asthma, bronchitis and Barretts Esophagus (a pre-cancerous condition).
The technology has additional applications in urology, obesity and drug delivery which are in the early stages of development.
Vysera's Medical Scientific Advisory Board includes world leading clinicians, located at the Mayo Clinic, Beth Israel Hospital (Harvard Medical School) and Sahlgrenska Hospital in Gothenburg, Sweden. The Medical Scientific Advisory Board provides input and direction to product design, application and associated clinical procedures; with the clinicians providing facilities for extensive testing and product evaluation in a pre-clinical and clinical environment.
|
Open
|
|
|
BMR House, Parkmore Business Park West
|
Galway
|
|
IE
|
Ireland
|
|
Vysera Biomedical
|
|
Pharmaceuticals & Biotechnology
|